![Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 — REMAP-CAP Trial Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 — REMAP-CAP Trial](https://images.squarespace-cdn.com/content/v1/5cde3c7d9a69340001d79ffe/1649810628828-F9ZKPZWV8U0OTUEJPOG4/Forest+plots+March+2022+colour.jpg?format=1000w)
Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 — REMAP-CAP Trial
![REMAP-CAP awarded Critical Care Team of the Year at The BMJ Awards 2021 | Imperial News | Imperial College London REMAP-CAP awarded Critical Care Team of the Year at The BMJ Awards 2021 | Imperial News | Imperial College London](https://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1634038880417_mainnews2012_x1.jpg)
REMAP-CAP awarded Critical Care Team of the Year at The BMJ Awards 2021 | Imperial News | Imperial College London
![Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients | Imperial News | Imperial College London Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients | Imperial News | Imperial College London](https://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1608721925123_mainnews2012_x1.jpg)
Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients | Imperial News | Imperial College London
![How will 'mega-trials' identify the most effective treatments for COVID-19, and when will they report? - Coronavirus: the science explained - UKRI How will 'mega-trials' identify the most effective treatments for COVID-19, and when will they report? - Coronavirus: the science explained - UKRI](https://coronavirusexplained.ukri.org/images/article/remap-cap-trial.png)